[Wang, Shu-zhi; Wang, SZ; Chen, Ke-qian; Wang, Zong-bao; Wang, ZB; Zhang, Yu-qing] Univ South China, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang Med Sch, Hengyang 421001, Peoples R China.

[Wang, Shu-zhi; Wang, SZ; Chen, Ke-qian; Wang, Zong-bao; Wang, ZB; Zhang, Yu-qing] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dru, Sch Pharmaceut Sci, Hengyang 421001, Peoples R China.

[Wang, SZ ; Wang, ZB] U

Univ South China, Inst Pharm & Pharmacol, Sch Pharmaceut Sci, Hengyang Med Sch, Hengyang 421001, Peoples R China.

Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dru, Sch Pharmaceut Sci, Hengyang 421001, Peoples R China.

aloin;angiogenesis modulator;angiogenic factor;berberine;canopy FGF signaling regulator 1;canopy FGF signaling regulator 2;canopy FGF signaling regulator 3;canopy FGF signaling regulator 4;canopy FGF signaling regulator 5;cisplatin;dexmedetomidine;liraglutide;microRNA;microRNA 30a;microRNA 30e;unclassified drug;CNPY2 protein, human;signal transducing adaptor protein;angiogenesis;cancer chemotherapy;cancer mortality;cancer prognosis;cardiovascular disease;cerebral ischemia reperfusion injury;colorectal cancer;congenital malformation;early onset epileptic encephalopathy;esophageal squamous cell carcinoma;gastritis;glioma;heart failure;heart infarction;human;hypoxia;ischemic heart disease;liver cell carcinoma;lung adenocarcinoma;lung cancer;medical research;morbidity;myocardial ischemia reperfusion injury;non small cell lung cancer;nonalcoholic fatty liver;nonhuman;Parkinson disease;prostate cancer;renal cell carcinoma;reperfusion injury;Short Survey;spinal cord ischemia reperfusion injury;stomach cancer;tumor invasion;uterine cervix cancer;cardiovascular disease;liver tumor;lung tumor;male;metabolism;nonalcoholic fatty liver;pathology;reperfusion injury;Adaptor Proteins, Signal Transducing;Cardiovascular Diseases;Humans;Liver Neoplasms;Lung Neoplasms;Male;Non-alcoholic Fatty Liver Disease;Reperfusion Injury

药学与生物科学学院